CVE-2017-12716 Explained : Impact and Mitigation

Pacemakers manufactured by Abbott Laboratories, specifically the Accent and Anthem models before August 28, 2017, have vulnerabilities that allow unencrypted transmission of patient data through RF communications.

Understanding CVE-2017-12716

This CVE involves the lack of encryption in patient data transmission by specific pacemaker models.

What is CVE-2017-12716?

Abbott Laboratories' Accent and Anthem pacemakers, produced before August 28, 2017, can send patient data via RF communications without encryption.
These pacemakers also store optional patient information without encryption.

The Impact of CVE-2017-12716

CVSS v3 base score: 3.1
Vector string: AV:A/AC:H/PR:N/UI:N/S:U/C:L/I:N/A:N
Abbott Laboratories released a firmware update to address and reduce the risks associated with these vulnerabilities.

Technical Details of CVE-2017-12716

This section provides more in-depth technical insights into the CVE.

Vulnerability Description

Missing encryption of sensitive patient data in Accent and Anthem pacemakers.

Affected Systems and Versions

Product: Accent and Anthem
Vendor: Abbott Laboratories
Versions: All versions of pacemakers manufactured before August 28, 2017

Exploitation Mechanism

Unencrypted transmission of patient data through RF communications

Mitigation and Prevention

Learn how to mitigate and prevent the risks associated with CVE-2017-12716.

Immediate Steps to Take

Ensure the pacemaker firmware is updated with the latest version from Abbott Laboratories.
Follow any specific guidance provided by the manufacturer for securing patient data.

Long-Term Security Practices

Regularly monitor for firmware updates and security advisories from Abbott Laboratories.
Implement encryption protocols for sensitive patient data transmission.

Patching and Updates

Apply firmware updates promptly to address vulnerabilities and enhance security measures.